Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy. The privately held company was founded in 2018 with the mission to transform lymphatic and vein care through innovative patient-centric platforms.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/03/22 | $26,000,000 | Series B |
3x5 Partners Arboretum Ventures Asahi Kasai Ventures Cadence Healthcare Ventures Scientific Health Development | undisclosed |
